AtriCure (ATRC) Cash & Equivalents Growth (1y) (2011 - 2026)
AtriCure (ATRC) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 130.27 Bn | 125.06 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 46.53 Bn | 45.72 Bn | 2.15 Bn | 21.89% |
| 3 | Alcon | 33.83 Bn | 32.17 Bn | 1.53 Bn | 5,969.23% |
| 4 | Medline | 33.52 Bn | 31.28 Bn | 1.84 Bn | - |
| 5 | Resmed | 30.14 Bn | 28.48 Bn | 890.98 Mn | 78.03% |
| 6 | West Pharmaceutical Services | 23.49 Bn | 23.06 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 14.77 Bn | 14.20 Bn | 1.10 Bn | 5.06% |
| 8 | Cooper Companies | 14.10 Bn | 13.96 Bn | 735.40 Mn | 19.45% |
| 9 | Baxter International | 12.55 Bn | 10.53 Bn | 891.00 Mn | -12.07% |
| 10 | AtriCure | 1.83 Bn | 1.68 Bn | 109.31 Mn | 46.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.33% |
| Dec 31, 2025 | 36.43% |
| Sep 30, 2025 | 13.45% |
| Jun 30, 2025 | 11.09% |
| Mar 31, 2025 | 53.75% |
| Dec 31, 2024 | 45.56% |
| Sep 30, 2024 | 61.71% |
| Jun 30, 2024 | 57.70% |
| Mar 31, 2024 | -16.00% |
| Dec 31, 2023 | 45.11% |
| Sep 30, 2023 | 65.08% |
| Jun 30, 2023 | 23.25% |
| Mar 31, 2023 | 174.83% |
| Dec 31, 2022 | 33.09% |
| Sep 30, 2022 | 22.41% |
| Jun 30, 2022 | -19.32% |
| Mar 31, 2022 | -67.04% |
| Dec 31, 2021 | 4.08% |
| Sep 30, 2021 | 19.49% |
| Jun 30, 2021 | -23.61% |